|
1
|
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.
|
Hypertension
|
2009
|
2.00
|
|
2
|
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha.
|
Hypertension
|
2005
|
1.95
|
|
3
|
Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats.
|
Hypertension
|
2005
|
1.95
|
|
4
|
Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia.
|
Methods Mol Med
|
2006
|
1.94
|
|
5
|
Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade.
|
Hypertension
|
2008
|
1.78
|
|
6
|
Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion.
|
Hypertension
|
2006
|
1.58
|
|
7
|
Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats.
|
Hypertension
|
2009
|
1.49
|
|
8
|
Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats.
|
Am J Hypertens
|
2007
|
1.26
|
|
9
|
Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension.
|
Am J Hypertens
|
2011
|
1.24
|
|
10
|
Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension.
|
Hypertension
|
2011
|
1.14
|
|
11
|
Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance.
|
Am J Obstet Gynecol
|
2011
|
1.04
|
|
12
|
Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants.
|
Am J Physiol Regul Integr Comp Physiol
|
2010
|
1.00
|
|
13
|
Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats.
|
Am J Physiol Regul Integr Comp Physiol
|
2011
|
0.96
|
|
14
|
Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation.
|
Int J Interferon Cytokine Mediat Res
|
2011
|
0.96
|
|
15
|
Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α.
|
Am J Physiol Regul Integr Comp Physiol
|
2012
|
0.95
|
|
16
|
Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy.
|
Am J Hypertens
|
2009
|
0.95
|
|
17
|
L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats.
|
Am J Physiol Regul Integr Comp Physiol
|
2011
|
0.93
|
|
18
|
Renal medullary endothelin-1 is decreased in Dahl salt-sensitive rats.
|
Am J Physiol Regul Integr Comp Physiol
|
2011
|
0.88
|
|
19
|
17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats.
|
Am J Obstet Gynecol
|
2009
|
0.86
|
|
20
|
Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats.
|
Am J Hypertens
|
2010
|
0.86
|
|
21
|
Role of 20-hydroxyeicosatetraenoic acid in mediating hypertension in response to chronic renal medullary endothelin type B receptor blockade.
|
PLoS One
|
2011
|
0.85
|
|
22
|
Inducible nitric oxide synthase inhibition attenuates renal hemodynamics during pregnancy.
|
Hypertension
|
2002
|
0.81
|